Rigel Pharmaceuticals Stock Target Price and Analyst Consensus
| RIGL Stock | USD 26.70 0.61 2.34% |
The current analyst and expert consensus on Rigel Pharmaceuticals is Buy with 4 hold recommendations. The current projected Rigel Pharmaceuticals target price consensus is 4.17 with 6 analyst opinions. One of the most common ways Rigel Pharmaceuticals analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Rigel Pharmaceuticals vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Rigel Pharmaceuticals. We strongly encourage you to use your own analysis of Rigel Pharmaceuticals to validate this buy or sell advice. Rigel Pharmaceuticals recommendation module provides expert sentiment on the projected Rigel Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 6.7954.
Lowest Forecast 3.79 | Highest Forecast 4.63 | Target Price 4.17 |
Rigel |
It's important to approach Rigel Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Rigel Pharmaceuticals price targets
Rigel Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Rigel Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Rigel Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Rigel Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Rigel Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Rigel Pharmaceuticals is a key component of Rigel Pharmaceuticals valuation and have some predictive power on the future returns of a Rigel Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Entertainment Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Momentum Invested over 60 shares | |
 | Impulse Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | FinTech Invested over 40 shares | |
 | Video Games Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Chemicals Invested over 30 shares | |
 | Business Services Invested few shares | |
 | Manufacturing Invested over 30 shares | |
Check out Macroaxis Advice on Rigel Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.